Henry Schein, Inc., Melville, N.Y., a health care solutions distributor to office-based dental and medical practitioners, has acquired Biotech Dental S.A.S.
Don’t miss any content from Distribution Strategy Group. Join our list.
Biotech, headquartered in Salon-de-Provence, France, provides dental implants, clear aligners and innovative digital dental software. Biotech manufactures custom abutments and implants under the Kontact™ brand and clear aligners under the Smilers® brand. In addition, the company offers technology solutions such as Nemotec and LaGalaxy®.
“We at Henry Schein welcome our new Biotech Dental colleagues and are most excited about the opportunity to bring Biotech Dental’s software products to our customers,” said Stanley M. Bergman, CEO of Henry Schein.
“Together with our existing portfolio of software products, Henry Schein and Biotech Dental will create a digital workflow that provides a seamless journey for our customers to increase case acceptance and improve clinical outcomes for practitioners. The integration of Biotech Dental’s software with Henry Schein One’s industry-leading practice management software solutions will help customers streamline their clinical as well as administrative workflow for the ultimate benefit of patients.”
